From January 24, 2024 to March 31, 2024, the company has repurchased 1,646,320 shares, representing 0.48% for CNY 27.78 million. With this, the company has completed the repurchase of 1,646,320 shares, representing 0.48% for CNY 27.78 million under the buyback announced on January 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.74 CNY | +0.60% | +2.64% | -22.89% |
05-06 | China Approves Tianyu Pharma's Heart Medication | MT |
04-30 | Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024. | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.89% | 793M | |
+26.36% | 45.33B | |
+38.49% | 25.36B | |
+27.35% | 16.7B | |
+21.09% | 14.59B | |
+72.30% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024.